Canada markets close in 42 minutes

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.09+2.18 (+9.52%)
As of 03:18PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close22.91
Open23.58
Bid25.00 x 100
Ask25.16 x 200
Day's Range23.33 - 25.22
52 Week Range20.67 - 39.83
Volume704,492
Avg. Volume1,240,098
Market Cap3.116B
Beta (5Y Monthly)0.78
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results

    PASADENA, Calif., May 09, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a conference call today, May 9, 2024, at 4:30 p.m. ET to discuss the results.

  • Business Wire

    Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma

    PASADENA, Calif., May 02, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a $50 million milestone payment was received from Royalty Pharma plc (NASDAQ: RPRX). This milestone was triggered after the completion of enrollment of the Phase 3 OCEAN(a) - Outcomes Trial of olpasiran, being conducted by Amgen (NASDAQ: AMGN). Pursuant to its 2016 agreement with Amgen and 2022 agreement with Royalty Pharma, Arrowhead is further eligible to receive up to an additional $375 million from

  • Business Wire

    Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences

    PASADENA, Calif., April 29, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: